Commission Implementing Decision (EU) 2021/183 of 12 February 2021 amending Implementing Decision (EU) 2017/2453 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified oilseed rapes (notified under document C(2021) 823) (Only the Dutch and German texts are authentic) (Text with EEA relevance)

• CELEX: Implementing Decision (EU) 2021/183
• Articles: 2

Article 1 Amendments to Implementing Decision (EU) 2017/2453

Implementing Decision (EU) 2017/2453 is amended as follows:

(1)

point (a) of Article 7(1) is replaced by the following:

‘(a)

Bayer Agriculture BV, Belgium, representing Bayer CropScience LP, United States.’;

(2)

point (a) of Article 9 is replaced by the following:

‘(a)

Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium.’;

(3)

point (a)(1) of the Annex is replaced by the following:

‘(1)

Name: Bayer Agriculture BV, Belgium

Address: Scheldelaan 460, 2040 Antwerp, Belgium

on behalf of

Bayer CropScience LP, 800 N. Lindbergh Boulevard, St Louis, Missouri, 63167, United States;

and’.

Article 2 Addressee

This Decision is addressed to:

(a)

Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium; and

(b)

BASF SE, Carl-Bosch-Str. 38, 67063 Ludwigshafen, Germany.